Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
- 7 July 1999
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (4) , 539-555
- https://doi.org/10.1016/s0006-2952(99)00035-0
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Induction of Erythroid Differentiation in Leukemic K562 Cells by an S-Adenosylhomocysteine Hydrolase Inhibitor, AristeromycinBiochemical and Biophysical Research Communications, 1995
- Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell lineZeitschrift für Krebsforschung und Klinische Onkologie, 1994
- Nucleoside Analogues as Chemotherapeutic Agents: A ReviewNucleosides and Nucleotides, 1992
- Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurinExperimental Cell Research, 1990
- Inhibition of DNA synthesis causes stem cell differentiation: Induction of teratocarcinoma F9 cell differentiation with nucleoside analogues of DNA-synthesis inhibitors and their inducing abilities counterbalanced specifically by normal nucleosidesBiochemical and Biophysical Research Communications, 1989
- Effects of maturational agents on expression and secretion of two partially characterized high molecular weight milk‐related glycoproteins in MCF‐7 breast carcinoma cellsJournal of Cellular Physiology, 1986
- Involvement of ribonucleotide reductase in cellular differentiationBioscience Reports, 1984
- DNA polymerase and thymidine kinase activities in MC-29 virus-induced transplantable hepatoma and the effect of cytostatic treatment on these activitiesChemico-Biological Interactions, 1982
- The incorporation of 5-fluoro-2′-deoxyuridine into DNA of mammalian tumor cellsBiochemical and Biophysical Research Communications, 1981
- Role of ribonucleotide reductase in expression of the neoplastic programLife Sciences, 1981